Sunday, Nov 01, 2020
Focus on the big picture

FDA, EU diverge on AstraZeneca COVID-19 vaccine

Reuters, 02 Oct 2020
The FDA has broadened its investigation of a serious illness in AstraZeneca’s COVID-19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists


Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Related Articles